The results, presented in Stockholm at EuroPRevent 2009, reflect what many other studies have indicated, but, says investigator Professor Haakon Meyer from the University of Oslo and Norwegian Institute of Public Health, these results provide a picture of the long-term, absolute "real life" risk.
Behind his conclusions lies a far-reaching follow-up study which began in 1974 with an invitation to every middle aged man and woman (aged 35-49) living in three counties of Norway to take part in a basic cardiovascular screening examination. The invitation had a huge response, with 91% attending for the baseline screen.
Over the next three decades deaths were recorded by linkage to the Norwegian population registry and, between 2006 and 2008, those surviving responded to a follow-up questionnaire. This allowed division of the participants according to their smoking status – never-smokers, ex-smokers, current smokers of 1-9 cigarettes a day, 10-19 cigarettes a day and more than 20 cigarettes a day (the last group referred to as "heavy smokers").
Results showed that, from the original 54,075 participants, 13,103 had died by the time of follow-up. But it was a significant finding that, of these, 45% of the heavy-smoking men had died during the 30 years, compared to just 18% of the never-smokers. Similarly, 33% of the heavy-smoking women had died, but only 13% of the never-smokers.
"These results show what a tremendous impact smoking has on mortality," says Professor Meyer. "We are talking about very high numbers of people."
A similar pattern was seen in the cardiovascular incidence rates reported in the follow-up questionnaire. In men the cumulative incidence of myocardial infarction was 10% in never-smokers and 21% in heavy smokers; in women 4% in never-smokers and 11% in heavy smokers. There were also strong associations found between smoking and stroke and diabetes.
"What these results show is the cumulative long-term association between smoking and death and cardiovascular risk," says Professor Meyer. "Around two-thirds of the middle-aged heavy-smoking men and half the heavy-smoking women had died or had a cardiovascular disease within the next 30 years. The incidence was much lower in never-smokers and reflects the tremendously adverse effect of smoking on health and longevity. The difference in outcome between the never-smokers and heavy smokers was substantial.
"This study underlines the public health messages about smoking. We have seen declines in the prevalence of smoking in developed countries, but challenges still remain. Certain population groups – young women, immigrant communities – still have high rates of smoking, and there's more to be done here."
1. Morbidity and mortality among smokers and non-smokers - 30 years follow-up of 54,000 middle-aged Norwegian women and men. Haakon Meyer, 7 May 2009, 15.30-16.30, Poster area.
2. EuroPRevent 2009 takes place in Stockholm, Sweden, on 6-9 May and is organised by The European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a Registered Branch of the European Society of Cardiology.
3. Cardiovascular disease is the main cause of mortality in Europe, responsible for more than 2 million deaths per year. Many of these deaths could be prevented with the full adoption and application of prevention policies.
4. The full scientific programme of EuroPRevent 2009 is available at http://spo.escardio.org/Welcome.aspx?eevtid=30
5. More information on EuroPRevent 2009 is available from the ESC's press office at email@example.com OR 00 33 492 94 86 27.
ESC Press Office | EurekAlert!
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences